C 2011

Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population

BIENERTOVÁ VAŠKŮ, Julie, Petr BIENERT, Filip ZLÁMAL, Josef TOMANDL, Martin FOREJT et. al.

Basic information

Original name

Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population

Name in Czech

Adipsin (komplementový faktor D) jako nový biomarker distribuce tělesného tuku u extrémně obézní české populace

Authors

BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, guarantor, belonging to the institution), Petr BIENERT (203 Czech Republic, belonging to the institution), Filip ZLÁMAL (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Martin FOREJT (203 Czech Republic, belonging to the institution), Zlata PISKÁČKOVÁ (203 Czech Republic, belonging to the institution), Martin VAVŘINA (203 Czech Republic, belonging to the institution), Jana KUDĚLKOVÁ (203 Czech Republic, belonging to the institution) and Anna VAŠKŮ (203 Czech Republic, belonging to the institution)

Edition

1. vyd. New York, Body Fat: Composition, Measurements and Reduction Procedures, p. 14-27, 13 pp. Body Fat: Composition, Measurements and Reduction, 2011

Publisher

Novapublishers

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30202 Endocrinology and metabolism

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/11:00052327

Organization unit

Faculty of Medicine

ISBN

978-1-61324-332-9

Keywords (in Czech)

adipsin; morbidní obezita; distribuce tělesného tuku

Keywords in English

adipsin; morbid obesity; body fat distribution
Změněno: 3/2/2012 10:34, Mgr. Michal Petr

Abstract

V originále

In this study, we identified strong positive correlations of adipsin plasma concentration with parameters of body fat distribution in extremely obese Central-European population, such as percentage of body fat and waist circumference, both considered important negative risk factors for obesity-associated comorbidities. More research is required to provide a better insight into the role of adipsin in obesity development to elucidate the underlying pathophysiological mechanisms of observed correlations.

In Czech

V této studii podáváme důkazy o silné závislosti hladin adipsinu na celkovém % tukové tkáně u morbidně obézní české populace.